Lifestyle

Sanofi, GSK, CSL Tapped to Expand US Bird Flu Vaccine Supply

GSK, Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, a health official said on Friday during a press briefing.